Dose intensification of Busulfan in the preparative regimen is associated with improved survival: A Phase I/II Controlled, Randomized Study

Dose intensity is important for disease control in patients undergoing allogeneic stem cell transplantation. We conducted a phase I/II controlled adoptive randomized study to determine the optimal dosing schedule of i.v. busulfan. Patients with advanced hematologic malignancies, ≤ 75 years with HLA-...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Parmar, S, Rondon, G, deLima, M, Thall, P, Bassett, R, Anderlini, P, Kebriaei, P, Khouri, I, Ganesan, P, Champlin, R, Giralt, S
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4052712/
https://ncbi.nlm.nih.gov/pubmed/23220013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2012.12.001
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados